These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10401851)

  • 1. Is epistaxis evidence of end-organ damage in patients with hypertension?
    Lubianca Neto JF; Fuchs FD; Facco SR; Gus M; Fasolo L; Mafessoni R; Gleissner AL
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1111-5. PubMed ID: 10401851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathology of visible blood vessels on the nasal septum in children with epistaxis.
    Montague ML; Whymark A; Howatson A; Kubba H
    Int J Pediatr Otorhinolaryngol; 2011 Aug; 75(8):1032-4. PubMed ID: 21676473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the association between epistaxis and the severity of hypertension.
    Lubianca-Neto JF; Bredemeier M; Carvalhal EF; Arruda CA; Estrella E; Pletsch A; Gus M; Lu L; Fuchs FD
    Am J Rhinol; 1998; 12(4):269-72. PubMed ID: 9740920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of association between hypertension and epistaxis: a population-based study.
    Fuchs FD; Moreira LB; Pires CP; Torres FS; Furtado MV; Moraes RS; Wiehe M; Fuchs SC; Lubianca Neto JF
    Blood Press; 2003; 12(3):145-8. PubMed ID: 12875475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the nasal mucous membrane and blood vessels in hypertensive vascular disorders and atherosclerosis].
    Derbeneva TN; Guterman GM
    Vestn Otorinolaringol; 1971; 33(3):73-8. PubMed ID: 5097352
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension in patients presenting with epistaxis.
    Herkner H; Laggner AN; Müllner M; Formanek M; Bur A; Gamper G; Woisetschläger C; Hirschl MM
    Ann Emerg Med; 2000 Feb; 35(2):126-30. PubMed ID: 10650229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A blind area of origins of epistaxis: technical or cognitive?
    Wei W; Lai Y; Zang C; Luo J; Zhu B; Liu Q; Liu Y
    Eur Arch Otorhinolaryngol; 2018 Jun; 275(6):1501-1505. PubMed ID: 29691639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analyses of patients with intractable epistaxis originated from deep-seated nasal cavity].
    Xu T; Li N; Jiang Y; Yu H; Yu L; Jiang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jul; 50(7):556-9. PubMed ID: 26695977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile of idiopathic epistaxis in a hospital.
    Bhatta R
    JNMA J Nepal Med Assoc; 2012; 52(188):167-71. PubMed ID: 23591247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REKAS (recurrent epistaxis from Kiesselbach's area syndrome).
    Mladina R
    Chir Maxillofac Plast; 1985; 15(3):91-5. PubMed ID: 3869921
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective clinical study of bleeding sites in idiopathic adult posterior epistaxis.
    Chiu TW; McGarry GW
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):390-3. PubMed ID: 17765763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey.
    Cuspidi C; Ambrosioni E; Mancia G; Pessina AC; Trimarco B; Zanchetti A;
    J Hypertens; 2002 Jul; 20(7):1307-14. PubMed ID: 12131527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for recurrent spontaneous epistaxis.
    Abrich V; Brozek A; Boyle TR; Chyou PH; Yale SH
    Mayo Clin Proc; 2014 Dec; 89(12):1636-43. PubMed ID: 25458126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.
    Shigematsu Y; Hamada M; Mukai M; Matsuoka H; Sumimoto T; Hiwada K
    J Hypertens; 1995 Jan; 13(1):155-60. PubMed ID: 7759846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of orthostatic hypertension and hypotension with target organ damage in middle and old-aged hypertensive patients].
    Fan XH; Sun K; Zhou XL; Zhang HM; Wu HY; Hui RT
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):220-4. PubMed ID: 21418863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between silent cerebral white matter lesions and left ventricular mass and geometry in essential hypertension.
    Sierra C; de la Sierra A; Paré JC; Gómez-Angelats E; Coca A
    Am J Hypertens; 2002 Jun; 15(6):507-12. PubMed ID: 12074351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism.
    Shigematsu Y; Hamada M; Okayama H; Hara Y; Hayashi Y; Kodama K; Kohara K; Hiwada K
    Hypertension; 1997 Mar; 29(3):723-7. PubMed ID: 9052887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis.
    Folz BJ; Wollstein AC; Lippert BM; Werner JA
    Am J Rhinol; 2005; 19(1):65-70. PubMed ID: 15794077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.
    Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Magrini F; Zanchetti A
    Blood Press; 2005; 14(1):25-31. PubMed ID: 15823944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
    Wachtell K; Olsen MH; Dahlöf B; Devereux RB; Kjeldsen SE; Nieminen MS; Okin PM; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H
    J Hypertens; 2002 Mar; 20(3):405-12. PubMed ID: 11875307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.